154 related articles for article (PubMed ID: 30165098)
41. Nanocrystal-based gel of apremilast ameliorates imiquimod-induced psoriasis by suppressing inflammatory responses.
Parmar PK; Sharma N; Wasil Kabeer S; Rohit A; Bansal AK
Int J Pharm; 2022 Jun; 622():121873. PubMed ID: 35640806
[TBL] [Abstract][Full Text] [Related]
42. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
43. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
44. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides.
Kang H; DeLong R; Fisher MH; Juliano RL
Pharm Res; 2005 Dec; 22(12):2099-106. PubMed ID: 16184444
[TBL] [Abstract][Full Text] [Related]
45. Dendrosome-dendriplex inside liposomes: as a gene delivery system.
Movassaghian S; Moghimi HR; Shirazi FH; Torchilin VP
J Drug Target; 2011 Dec; 19(10):925-32. PubMed ID: 22023509
[TBL] [Abstract][Full Text] [Related]
46. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
47. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth.
Whitmore M; Li S; Huang L
Gene Ther; 1999 Nov; 6(11):1867-75. PubMed ID: 10602382
[TBL] [Abstract][Full Text] [Related]
48. Induction of a robust immune response against avian influenza virus following transdermal inoculation with H5-DNA vaccine formulated in modified dendrimer-based delivery system in mouse model.
Bahadoran A; Ebrahimi M; Yeap SK; Safi N; Moeini H; Hair-Bejo M; Hussein MZ; Omar AR
Int J Nanomedicine; 2017; 12():8573-8585. PubMed ID: 29270010
[TBL] [Abstract][Full Text] [Related]
49. Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse model.
Bahramizadeh M; Bahramizadeh M; Kiafar B; Jafarian AH; Nikpoor AR; Hatamipour M; Esmaily H; Rezaeemehr Z; Golmohammadzadeh S; Moosavian SA; Jafari MR
Int J Pharm; 2019 Oct; 569():118623. PubMed ID: 31419462
[TBL] [Abstract][Full Text] [Related]
50. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS.
Cardoso AL; Simões S; de Almeida LP; Plesnila N; Pedroso de Lima MC; Wagner E; Culmsee C
J Control Release; 2008 Dec; 132(2):113-23. PubMed ID: 18796321
[TBL] [Abstract][Full Text] [Related]
51. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.
Garbuzenko OB; Saad M; Betigeri S; Zhang M; Vetcher AA; Soldatenkov VA; Reimer DC; Pozharov VP; Minko T
Pharm Res; 2009 Feb; 26(2):382-94. PubMed ID: 18958402
[TBL] [Abstract][Full Text] [Related]
52. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase.
Depieri LV; Borgheti-Cardoso LN; Campos PM; Otaguiri KK; Vicentini FT; Lopes LB; Fonseca MJ; Bentley MV
Eur J Pharm Biopharm; 2016 Aug; 105():50-8. PubMed ID: 27224855
[TBL] [Abstract][Full Text] [Related]
53. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.
Khoury M; Escriou V; Courties G; Galy A; Yao R; Largeau C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2008 Aug; 58(8):2356-67. PubMed ID: 18668557
[TBL] [Abstract][Full Text] [Related]
54. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
Wang J; Ayano E; Maitani Y; Kanazawa H
Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734
[TBL] [Abstract][Full Text] [Related]
55. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
56. Cationic liposome-mediated delivery of siRNAs in adult mice.
Sioud M; Sørensen DR
Biochem Biophys Res Commun; 2003 Dec; 312(4):1220-5. PubMed ID: 14652004
[TBL] [Abstract][Full Text] [Related]
57. Co-encapsulation of metformin and ginger into the liposomes:
Jenabikordi K; Zadeh BSM; Rezaie A
Drug Dev Ind Pharm; 2021 Sep; 47(9):1447-1458. PubMed ID: 35266419
[TBL] [Abstract][Full Text] [Related]
58. Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA).
Firouzmand H; Badiee A; Khamesipour A; Heravi Shargh V; Alavizadeh SH; Abbasi A; Jaafari MR
Acta Trop; 2013 Dec; 128(3):528-35. PubMed ID: 23916506
[TBL] [Abstract][Full Text] [Related]
59. In Vitro and In Vivo Tumor-Targeting siRNA Delivery Using Folate-PEG-appended Dendrimer (G4)/α-Cyclodextrin Conjugates.
Ohyama A; Higashi T; Motoyama K; Arima H
Bioconjug Chem; 2016 Mar; 27(3):521-32. PubMed ID: 26715308
[TBL] [Abstract][Full Text] [Related]
60. Structure-activity relationships of fluorinated dendrimers in DNA and siRNA delivery.
Wang M; Cheng Y
Acta Biomater; 2016 Dec; 46():204-210. PubMed ID: 27662807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
